MRD / Regn No. : 20190000505 Date : 23/07/2026
Patient Name : Nijamudeen Pakir Rowther Age & Gender : 70 Yrs. / Male
Contact No. : 9629641879 UHID :
Ht / Wt / BMI : 165.2 / 77.4 / 28.36 BP S / BP D : 126 / 79
Allergies : NKA Referred By :
   
Problem List : CAD (04/Sep/2019) | TYPE 2 DM (04/Sep/2019) | HEART FAILURE STAGE B (06/Dec/2022) | DYSLIPIDEMIA (13/Aug/2024) | DIABETIC CELLULITIS (17/Jun/2025) |
Subjective : HAS CELLULITIS
Objective : DRY SKIN
Analysis : CAD,DIABETIC RETINOPATHY,HEART FAILURE STAGE B,TYPE 2 DM,DISTAL SENSORY NEUROPATHY,DYSLIPIDEMIA
Plan : ADD SEMAGLUTIDE,SEE ME IN 1 MONTH WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 206 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.80 % | POST PRANDIAL GLUCOSE (2HPP): 308 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 44 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 47 mg/dL | TGL TRIGLYCERIDE: 60 mg/dL | TOTAL CHO/HDL RATIO: 2.34 | TOTAL CHOLESTEROL: 103 mg/dl | VLDL: 12 mg/dl | A\G RATIO: 1.3 g/dl | ALBUMIN (SERUM): 4.33 g/dL | ALKALINE PHOSPHOTASE: 80 IU/L | DIRECT BILIRUBIN: 0.39 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 14 U/L | GLOBULIN: 3.36 g/dl | INDIRECT BILIRUBIN: 0.51 | SGOT (AST): 15 U/L | SGPT (ALT): 10 IU/L | TOTAL BILIRUBIN: 0.90 mg/dL | TOTAL PROTEIN: 7.69 g/dl
S# Generic (Trade) Name Route Dosage Usage Duration
1 EMPAGLIFLOZIN 25 MG
JARDIANCE 25 MG
Medicine For DIABETES HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
2 TELMISARTAN 80 MG
ERTIEL 80 MG
Medicine For HYPERTENSION
PO 0-0-1 AFTER FOOD
TILL NEXT VISIT
3 TABLET IMEGLIMIN 500 MG
IMEXTOR
Medicine For GLUCOSE CONTROL
PO 1-0-1 BEFORE FOOD
TILL NEXT VISIT
4 TABLET PREGABALIN SR 75 MG
PREGALIN SR 75 MG
Medicine For NEUROPATHY
0-0-1 AT BEDTIME
TILL NEXT VISIT
5 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
6 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL
SQ 0-0-28 UNITS AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
7 CAPSULE SEMAGLUTIDE
SEMASIZE 0.25
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 24/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: